Life Science

Cell and gene therapy (CGT) is a rapidly evolving field producing powerful new treatments for cancers and genetic diseases, and expanding into autoimmune disease, cardiovascular disease, musculoskeletal disease, and many others. The CGT field has generated great interest and hope among researchers, patient groups, and regulators, which has led to huge investments in R&D. Globally,…

Contract manufacturing is becoming increasingly vital in the pharmaceutical industry, particularly in cell and gene therapy due to the high demand for these innovative products. Kalorama Information’s report, Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs), provides comprehensive insights into this dynamic market.

Report Highlights:

• Biopharmaceutical Contract Manufacturing Market: In-depth analysis of…

 

 

 

 

This report provides an in-depth and up-to-date look into scientists’ use of the genome editing tool, CRISPR/Cas9. Our survey reveals that while the market is growing steadily, there are challenges confronting suppliers. For instance, Bioinformatics found that over a quarter of scientist respondents said they were highly or somewhat likely to switch away from their primary brand…

We’ve Spoken To Your Customers

Understanding the overall customer experience, from pre-purchase experience, to product experience, to post-purchase experience, is more important now than ever before. Customer experience offers an opportunity for suppliers to differentiate themselves from other suppliers in a crowded life science marketplace on something more than product performance and price. An excellent…

Outsourcing drug discovery represents the initial phase of the drug development process. By outsourcing segments of their drug discovery programs, pharmaceutical and biotechnology companies have discovered a cost-effective strategy that enhances hit-to-lead conversion and early identification of ineffective compounds. Outsourcing accelerates the drug discovery process, transforming the industry from low-end research services to high-value, sophisticated…

What is the size of the cell and gene therapy market? According to Cell Therapy and Gene Therapy Markets, 2020 from Kalorama Information, the global market for cell and gene therapy in 2020 is estimated to reach $3.9 billion, with most of the market focused on the treatment of cancer. This exciting period in the…

First published by BioInformatics in 2003, Advertising to Life Scientists is the indispensable guide to reaching your scientific audience. Improve the effectiveness of your advertising by understanding the messages and media that scientists consider most useful and appropriate.

This report explores the preferences, opinions, and impact of print and digital advertising on life scientists. This report provides…

Non-alcoholic steatohepatitis (NASH) is a serious liver disease characterized by inflammation and liver cell damage, which can lead to cirrhosis. Despite the absence of approved medications specifically for NASH, there are nearly 80 drug candidates in development. Kalorama Information’s report, NASH Drug Pipeline and Market Overview, provides an in-depth analysis of these drug candidates, including…

CAR-T Cell Therapy Market Review provides an insightful examination of CAR-T therapy, a revolutionary form of immunotherapy harnessing the body’s T cells to target and eradicate cancer cells. This report delves into the technology behind CAR-T, its application in treating diseases like acute lymphoblastic leukemia, DLBCL B-cell lymphomas, and multiple myeloma.

Key Objectives and Questions…